Search research articles
Contact Us
Filters
Showing results (201-210 of 210) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 210 results.
Nature
|
February 17, 2026
Publisher Correction: Psychedelics elicit their effects by 5-HT2A receptor-mediated G<sub>i</sub> signalling
Zheng Xu, Hongshuang Wang, Jingjing Yu, et al.
Journal of Hepatology
|
April 27, 2021
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
Jitao Wang, Zhiyun Hou, Jianxin Liu, et al.
Clinical and Molecular Hepatology
|
July 11, 2024
Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
Chuan Liu, Hong You, Qing-Lei Zeng, et al.
BMJ Open
|
July 11, 2024
Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China
Chuan Liu, Liting Zhang, Shuairan Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 4, 2026
Peginterferon α-2b Enhances HBsAg Loss in NA-Suppressed Low-HBsAg Chronic Hepatitis B Patients: Everest Study in China
Chan Xie, Bingliang Lin, Zhishuo Mo, et al.
The Lancet Regional Health. Western Pacific
|
July 30, 2021
Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study
Shuai Wang, Yifei Huang, Weiling Hu, et al.
Clinical and Molecular Hepatology
|
February 5, 2025
FIB-4plus Score: A novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): An international multicenter study
Bingtian Dong, Ruiling He, Shenghong Ju, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 23, 2021
Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study
Jingwen Ai, Jitao Wang, Dengxiang Liu, et al.
Hepatology International
|
October 12, 2023
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Jitao Wang, Qiran Zhang, Jingwen Ai, et al.
Hepatology International
|
April 11, 2022
Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Jitao Wang, Qiran Zhang, Jingwen Ai, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 210) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 210 results.
Nature
|
February 17, 2026
Publisher Correction: Psychedelics elicit their effects by 5-HT2A receptor-mediated G<sub>i</sub> signalling
Zheng Xu, Hongshuang Wang, Jingjing Yu, et al.
Journal of Hepatology
|
April 27, 2021
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
Jitao Wang, Zhiyun Hou, Jianxin Liu, et al.
Clinical and Molecular Hepatology
|
July 11, 2024
Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
Chuan Liu, Hong You, Qing-Lei Zeng, et al.
BMJ Open
|
July 11, 2024
Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China
Chuan Liu, Liting Zhang, Shuairan Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 4, 2026
Peginterferon α-2b Enhances HBsAg Loss in NA-Suppressed Low-HBsAg Chronic Hepatitis B Patients: Everest Study in China
Chan Xie, Bingliang Lin, Zhishuo Mo, et al.
The Lancet Regional Health. Western Pacific
|
July 30, 2021
Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study
Shuai Wang, Yifei Huang, Weiling Hu, et al.
Clinical and Molecular Hepatology
|
February 5, 2025
FIB-4plus Score: A novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): An international multicenter study
Bingtian Dong, Ruiling He, Shenghong Ju, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 23, 2021
Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study
Jingwen Ai, Jitao Wang, Dengxiang Liu, et al.
Hepatology International
|
October 12, 2023
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Jitao Wang, Qiran Zhang, Jingwen Ai, et al.
Hepatology International
|
April 11, 2022
Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Jitao Wang, Qiran Zhang, Jingwen Ai, et al.
Page
of 21